Calistoga Pharmaceuticals has named Carol Gallagher, Pharm. D., as CEO.

Dr. Paul Bleicher has stepped down from his post as chairman of Phase Forward.

Cell Therapeutics has appointed Christina Waters as the new president of Cell Therapeutics Europe.

Concert Pharmaceuticals announced that Steven Bernitz has joined the company as its senior vice president and chief business officer.

BT Pharma has named Prof. Thierry Hercend to the position of president of the supervisory board.

Ikaria Holdings announced the appointment of Michael Kennedy as senior vice president, engineering and operations.

Bristol-Myers Squibb announced that Christopher Perley has been named vice president and general manager of its Devens biologics manufacturing facility.

Pharmasset has named Richard Smith as its new vice president of investor relations and corporate communications.

David St. Peter, M.D. joins Pacira as vice president of medical education and scientific affairs.

Amgen has appointed Francois de Carbonnel to its board of directors.

Epiphany Biosciences announced that Dr. Charles Sanders has accepted the position of Lead Director.

Ariad Pharmaceuticals has appointed Massimo Radaelli, Ph.D. and Wayne Wilson to its board of directors.

Avexa announced that Nathan Drona will replace Stephen Cooper as chairman of the board while David Bottomley and Alan Boyd have been added to the board.

CytoDyn named Parviz Lalezari, M.D., to its Scientific Advisory Board.